Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11578135
Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
granted -
US 11571482
Human antibodies to S. aureus Hemolysin A toxin
granted -
US 11571636
Methods for quantitating individual antibodies from a mixture
granted -
US 11559576
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
granted -
US 11559564
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11559489
Tuning of release kinetics in hydrogels
granted -
US 11547101
Non-human animals having a disruption in a C9ORF72 locus
granted -
US 11548932
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11548947
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
granted -
US 11542326
Anti-IL-25 antibodies and uses thereof
granted -
US 11542317
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11535663
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
granted -
US 11535675
Antigen-binding proteins that antagonize leptin receptor
granted -
US 11530255
Human antibodies to Ebola virus glycoprotein
granted -
US 11525629
Target residual moisture content for lyophilized drug product
granted -
US 11525001
Anti-CD8 antibodies and uses thereof
granted -
US 11518804
Method of treating osteoarthritis with an antibody to NGF
granted -
US 11519020
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 11511001
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
granted -
US 11512309
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11505600
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
US 11505594
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11505593
Anti-VEGF protein compositions and methods for producing the same
granted